Tmunity Stock

tmunity.comBioTechFounded: 2015Funding to Date: $220.28MM

Tmunity is a clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy to patients with devastating diseases.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Tmunity, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Anne Chew Ph.D
Co-Founder, Advisor & Board Member
Usman Azam MD
President, Chief Executive Officer & Board Member
Graeme Bell
Chief Financial Officer & Executive Vice President
Jason Krentz
Chief Technology Officer & Head, Technical Operations
Michael Christiano
Executive Vice President and Chief Business Officer
Christina Coughlin MD
Chief Medical Officer & Executive Vice President
Bruce Blazar MD
Co-Founder & Advisor
Bruce Levine Ph.D
Co-Founder & Advisor
James Riley
Co-Founder & Advisor
Yangbing Zhao Ph.D
Co-Founder & Advisor
Carl June MD
Co-Founder & Chief Scientific Advisor

Board Members

Anne Chew Ph.D
Garry Nicholson
Patrick Gray
Usman Azam MD

Other companies like Tmunity in the BioTech sector

Sector
Last Round Est. Valuation
$143.8MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$138.75MM
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$289.42MM
Sector
Last Round Est. Valuation
$1.08B

News

Tmunity Therapeutics, a Philadelphia, PA-based T-cell immunotherapy company, closed a $75m Series B financing. The round was led by Andreessen Horowitz
Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of